Beijing Wandong Medical Technology Co., Ltd. Class A

Beijing Wandong Medical Technology Co., Ltd. Class A

SSSE:600055
10.03
CNY
-0.08
(-0.79%)
-0.49EPS
7.45BMarket Cap
Apr 16Next Earn
Beijing Wandong Medical Technology Co., Ltd. Class A
SSE:600055
(Shanghai Stock Exchange)

Recent

price

10.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.24
1.19
1.51
1.57
1.54
2.76
2.1
1.62
1.74
1.8
2.1
2.15
1.73
1.77
2.13
1.89
2.05
Revenue per Share
0.09
0.08
0.07
0.09
0.05
0.14
0.18
0.2
0.28
0.31
0.41
0.34
0.27
0.27
0.22
-0.32
-0.49
Basic EPS, GAAP
-0.02
-0.08
0.08
-0.04
-0.09
-0.5
0.21
-0.24
0.06
0.1
0.92
0.14
0.26
0.27
0.25
-0.49
- -
Free Cash Flow per Basic Share
0.04
0.03
0.04
0.03
0.03
0.08
0.06
0.11
0.05
0.1
0.05
0.13
0.11
0.12
0.13
0.13
- -
Dividend per Share
1.2
1.25
1.36
1.37
1.38
1.44
3.31
3.41
3.63
3.86
4.22
4.43
6.55
6.7
6.78
6.34
6.1
Book Value per Share
1.18
1.22
1.27
1.22
1.21
1.25
3.16
3.28
3.52
3.75
4.13
4.37
6.52
6.66
6.69
6.23
5.97
Tangible Book Value per Share
484
496
480
489
480
297
387
546
548
545
538
539
650
698
715
712
698
Basic Weighted Avg Shares
603
589
728
765
740
818
813
884
955
982
1,132
1,156
1,121
1,237
1,524
1,347
1,431
Sales/Revenue/Turnover
8.26
8.01
6.67
4.05
-0.67
2.98
4.79
11.57
18.05
20.58
26.43
16.61
11.97
8.11
7.51
-20.27
-25.08
Operating Margin (%)
17
16
18
21
17
24
32
35
38
39
39
37
35
36
39
45
- -
Depreciation Expense
42
40
34
44
26
40
72
109
153
169
221
183
175
189
157
-228
-345
Net Income, GAAP
6.11
22.44
13.42
1.06
7.73
14.51
15.58
14.86
13.81
13.67
17.25
13.01
10.6
10.56
4.92
- -
- -
Effective Tax Rate (%)
6.96
6.77
4.72
5.7
3.47
4.93
8.8
12.34
16.06
17.19
19.5
15.84
15.64
15.25
10.32
-16.92
-24.09
Profit Margin (%)
272
304
358
324
235
130
1,244
1,198
1,070
1,131
1,414
1,533
3,774
3,878
3,917
3,458
3,369
Working Capital
4
4
4
4
4
4
4
4
4
- -
13
14
16
11
14
16
8
LT Debt
588
611
670
674
678
711
1,858
1,902
2,018
2,184
2,378
2,503
4,711
4,821
4,878
4,568
4,401
Total Equity
5.27
4.05
3.98
2.4
-1.48
1.27
3.04
5.37
7.93
7.94
9.74
7.54
4.82
4.04
3.24
- -
- -
Return on Invested Capital (%)
6.72
6.15
5.45
6.15
4.1
5.7
5.47
6.26
8.06
8.25
9.82
7.62
4.96
3.92
3.24
- -
- -
Return on Capital (%)
7.42
6.74
5.42
6.57
3.85
5.9
5.74
6
8.05
8.33
10.1
7.83
5.01
4.05
3.32
-4.94
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
6
4
3
LT Borrowings
- -
- -
- -
LT Finance Leases
16
3
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
703
703
703
Market Capitalization
10,363
7,185
7,452

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
4,235
4,091
4,052
Cash, Cash Equivalents & STI
2,963
2,936
2,925
Accounts Receivable, Net
454
531
572
Inventories
525
357
275
Total Current Liabilities
784
686
683
Payables & Accruals
- -
- -
- -
ST Debt
6
4
3
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.74%
18.13%
-6.35%
Free Cash Flow
10.05%
-50.83%
-295.37%
Net Income, GAAP
-6.37%
-55.02%
-244.81%
Sales/Revenue/Turnover
5.52%
4.21%
-11.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
308
392
393
431
1,524
2025
373
470
- -
158
1,347
2026
407
468
397
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.07
0.04
0.06
0.22
2025
0.05
0.02
- -
-0.29
-0.32
2026
-0.02
-0.11
-0.07
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.13
2025
- -
- -
- -
- -
0.13
2026
- -
- -
- -
- -
- -
Business
Beijing Wandong Medical Technology Co., Ltd. engages in the research, development, manufacture, sale, and after-sales service of medical imaging equipment primarily in China with expanding global operations. The company offers digital X-ray radiography systems including panorama DR, ceiling DR, floor-mounted DR, U-arm DR, mobile DR, and vehicle-mounted DR; magnetic resonance imaging systems encompassing i_Vision 1.5T helium-free superconducting MRI, i_Open 0.5T/0.4T open MRI, and 3.0T MRI; X-ray computed tomography systems such as OpenCT and 128-slice cloud CT; digital subtraction angiography systems for vascular interventional therapy; dynamic flat-panel DRF systems for gastrointestinal and urogenital imaging; digital mammography systems; and ultrasound diagnostic equipment, providing comprehensive diagnostic solutions to hospitals, imaging centers, and medical institutions worldwide. Founded in 1955 and headquartered at Building 3, No. 9 Jiuxianqiao East Road, Chaoyang District, Beijing, China, it operates as a subsidiary of Midea Group since its 2021 acquisition and maintains R&D and manufacturing bases in Beijing and Suzhou with sales networks in over 70 countries. Recent developments include the launch of industry-first products such as full-frame DR, OpenCT, and 128-cloud CT over the past three years; strategic partnerships in Latin America with Nicaragua for public hospital equipment supply and Brazil for localized manufacturing and services; the opening of new international offices to bolster global expansion under its "4+2+4" strategy; and the commencement of operations at its Beijing R&D and manufacturing base in 2025 to advance intelligent manufacturing in high-end medical imaging.